Screener
Kura Oncology KURA Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Kura Oncology’s reported figures.
The source filing: Kura Oncology’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219481
FAQ
- What is Kura Oncology's free cash flow?
- Kura Oncology (KURA) reported free cash flow of -$85.98M in Q1 2026.
- How has Kura Oncology's free cash flow changed year-over-year?
- Kura Oncology's free cash flow decreased by 19.1% year-over-year, from -$72.22M to -$85.98M.
- What is the long-term trend for Kura Oncology's free cash flow?
- Over 3 years (2021 to 2024), Kura Oncology's free cash flow has grown at a 8.2% compound annual growth rate (CAGR), from -$105.7M to $133.85M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Kura Oncology's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude